Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET
Company Participants
Todd Friedman – Senior Director, Finance & Investor Relations
Christian Henry – President & Chief Executive Officer
Jim Gibson – Chief Financial Officer
Conference Call Participants
Jack Meehan – Nephron Research
David Westenberg – Piper Sandler
William Ruby – TD Cowen
Operator
Good afternoon, everyone. And welcome to the PacBio First Quarter 2025 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions]
Please also note today’s event is being recorded. At this time, I’d like to turn the floor over to Todd Friedman, Investor Relations. Sir, please go ahead.
Todd Friedman
Good afternoon. And welcome to PacBio’s first quarter 2025 earnings conference call. Earlier today, we issued a press release outlining the financial results we’ll be discussing on today’s call, a copy of which is available on the Investor’s section of our website at www.pacb.com or as furnished on Form 8-K available on the Securities and Exchange Commission website at www.sec.gov. A copy of our earnings presentation is also available on the Investor’s section of our website.
With me today are, Christian Henry, President and Chief Executive Officer; and Jim Gibson, Chief Financial Officer.
On today’s call we will make forward-looking statements including, among others, statements regarding predictions, estimates, expectations, and guidance .You should not place undue reliance on forward-looking statements because they are subject to assumptions, risks and uncertainties that could cause our actual results to differ materially from those projected or discussed.
Please review our SEC filings, including our most recent Forms 10-Q and 10-K and our press releases to better understand the risks and uncertainties that could cause results to differ. We disclaim any
Read the full article here
